GZMK and neoplasm: The Treg-C2-TNFRSF9 subtype was enriched in MI tumour samples, while the CD8T-C1-GZMK and CD8T-C2-IFNG clusters were predominantly found in NMI tumours and normal samples (Figure 3C and 3D).